How many patents does
Ludwig Institute For Cancer Research have?
patents
1,027
families
184
granted
245
applications
782
US
306
EP
166
WO
113
JP
52
CN
34
KR
19
GB
5
RoW
332
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Ludwig Institute For Cancer Research
Top ten assignees appearing on patents
2009 - 2018
| agenus | 65 |
| vegenics | 47 |
| acceleron pharma | 21 |
| kalobios pharmaceuticals | 18 |
| ionis pharmaceuticals | 14 |
| licentia patent-verwaltungs-gesell… 🛈 | 13 |
| wyeth | 12 |
| csl | 11 |
| argen-x | 11 |
| pacific edge biotechnology | 11 |
Ludwig Institute For Cancer Research
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| specific binding proteins and uses thereof | 81 | 2001 |
| methods and compositions based on alk1 antagonists for modulating angiogenesis and peric… 🛈 | 30 | 2008 |
| specific binding proteins and uses thereof | 29 | 2001 |
| prognosis prediction for melanoma cancer | 28 | 2007 |
| flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy | 23 | 1992 |
| vascular endothelial growth factor d (vegf-d) polypeptides and methods of use | 22 | 1996 |
| novel anti-cancer agents | 22 | 2010 |
| treatment method using egfr antibodies and src inhibitors and related formulations | 19 | 2007 |
| targeting vegf-b regulation of fatty acid transporters to modulate human diseases | 19 | 2006 |
| anti-gitr antibodies and methods of use thereof | 18 | 2014 |